NewLink Genetics Corp (NASDAQ:NLNK)
During the Trading Day
| 21.18 |  -1.64 / -7.19% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 21.18 | -0.0025 / -0.01% |
Volume: 4.5K |
Stock Price Forecast
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 34.00, with a high estimate of 51.00 and a low estimate of 26.00. The median estimate represents a +60.53% increase from the last price of 21.18.
Analyst Recommendations
The current consensus among 4 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since July, when it was unchanged from a rating.Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current Quarter
Earnings per Share
-$0.42
-$0.42
Sales
$287.5K
$287.5K
Reporting Date
Aug 06
Aug 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly -27.27%
Growthannually -41.06%
Sales
Growthquarterly -13.92%
Growthannually 9.06%
.
